Cellebrite Di Ltd. (CLBT) — 6-K Filings

6-K Filings (24)

• 6-K Filing — Dec 2, 2025
• Cellebrite Reports Q3 2025 Results — Nov 12, 2025 Risk: low
  Cellebrite DI Ltd. announced its third-quarter 2025 results via a press release on November 12, 2025. The press release, furnished as Exhibit 99.1, is incorpora
• Cellebrite Shareholders Approve All Proposals at Annual Meeting — Sep 22, 2025 Risk: low
  Cellebrite DI Ltd. announced on September 22, 2025, that its shareholders approved all proposals at the annual general meeting held on September 19, 2025. The a
• Cellebrite Sets Annual Shareholder Meeting for Sept 19 — Aug 15, 2025 Risk: low
  Cellebrite DI Ltd. announced on August 15, 2025, that its Annual General Meeting of Shareholders will take place on September 19, 2025, at 4:00 p.m. Israel time
• Cellebrite Names New CEO, Reports Q2 2025 Results — Aug 14, 2025 Risk: medium
  Cellebrite DI Ltd. announced its second-quarter 2025 results on August 14, 2025. The company also revealed that Thomas E. Hogan has been appointed as the new Ch
• Cellebrite Appoints New CFO, Dana Gerner Retires — Jul 8, 2025 Risk: low
  Cellebrite DI Ltd. announced on July 8, 2025, that David Barter has been appointed as the new Chief Financial Officer, succeeding Dana Gerner who is retiring. T
• Cellebrite to Acquire Corellium — Jun 5, 2025 Risk: medium
  On June 5, 2025, Cellebrite DI Ltd. announced its intention to acquire Corellium. This acquisition is expected to enhance Cellebrite's digital intelligence solu
• Cellebrite Reports Q1 2025 Results — May 14, 2025 Risk: low
  Cellebrite DI Ltd. announced its first-quarter 2025 results on May 14, 2025. The company filed a Form 6-K to report this information, which includes GAAP financ
• Cellebrite Reports Q4 and Full-Year 2024 Results — Feb 13, 2025 Risk: low
  Cellebrite DI Ltd. announced its fourth-quarter and full-year 2024 results on February 13, 2025. The company is a foreign private issuer filing a Form 6-K repor
• Cellebrite DI Ltd. Appoints Interim CEO Amid Leadership Transition — Jan 6, 2025 Risk: low
  On January 1, 2025, Thomas E. Hogan, the current chairman of the board of directors for Cellebrite DI Ltd., began serving as interim CEO. This change is part of
• Cellebrite DI Ltd. Reports Q3 2024 Results — Nov 6, 2024 Risk: low
  Cellebrite DI Ltd. announced its third-quarter 2024 results on November 6, 2024. The company is a foreign private issuer filing a Form 6-K report with the SEC.
• Cellebrite Triggers Share Price Milestone — Nov 4, 2024 Risk: low
  Cellebrite DI Ltd. announced on November 1, 2024, that the dollar volume-weighted average price of its ordinary shares exceeded $17.50 for the twentieth trading
• Cellebrite Shareholders Approve All Proposals at AGM — Sep 19, 2024 Risk: low
  Cellebrite DI Ltd. announced that its shareholders approved all proposals at the annual general meeting held on September 17, 2024. The approvals were made by t
• Cellebrite Completes Public Warrant Redemption — Sep 18, 2024 Risk: low
  On September 18, 2024, Cellebrite DI Ltd. announced the results of its previously disclosed redemption of all outstanding public warrants. The company is redeem
• Cellebrite Shares Hit $15 Milestone for 20th Day — Sep 16, 2024 Risk: low
  Cellebrite DI Ltd. announced on September 13, 2024, that the dollar volume-weighted average price of its ordinary shares exceeded $15.00 for the twentieth tradi
• Cellebrite Announces Public Warrant Redemption — Sep 6, 2024 Risk: low
  Cellebrite DI Ltd. filed a Form 6-K on September 6, 2024, to report on the redemption of all its outstanding public warrants. The company had previously issued
• Cellebrite Announces Warrant Redemption Fair Market Value — Aug 30, 2024 Risk: low
  On August 30, 2024, Cellebrite DI Ltd. announced the "Redemption Fair Market Value" for its outstanding public warrants. This announcement is in connection with
• Cellebrite DI Ltd. to Redeem All Public Warrants — Aug 27, 2024 Risk: medium
  On August 15, 2024, Cellebrite DI Ltd. issued a Redemption Notice to redeem all of its outstanding public warrants. These warrants were originally issued for th
• Cellebrite Shares Hit $12.50 Price Target — Aug 15, 2024 Risk: low
  Cellebrite DI Ltd. announced on August 14, 2024, that its ordinary shares achieved a dollar volume-weighted average price of at least $12.50 for the 20th tradin
• Cellebrite Adds Tech Veteran Troy K. Richardson to Board — Aug 14, 2024 Risk: low
  On August 14, 2024, Cellebrite DI Ltd. announced the appointment of Troy K. Richardson, a tech veteran, to its Board of Directors. This appointment is detailed
• Cellebrite Sets Annual Shareholder Meeting for Sept 17 — Aug 13, 2024 Risk: low
  Cellebrite DI Ltd. announced on August 13, 2024, that its Annual General Meeting of Shareholders will take place on September 17, 2024, at 4:00 p.m. Israel time
• Cellebrite Announces Q1 2024 Results — May 23, 2024 Risk: low
  Cellebrite DI Ltd. announced its first-quarter 2024 results on May 23, 2024. The company is a foreign private issuer based in Israel and filed a Form 6-K to rep
• Cellebrite DI Ltd. Announces Leadership Transition — Mar 6, 2024 Risk: medium
  Cellebrite DI Ltd. announced on March 6, 2024, that Haim Shani has concluded his tenure with the company as it transitions into its next growth phase. This anno
• Cellebrite Files 6-K for Q4 2023 Results — Feb 15, 2024 Risk: low
  Cellebrite DI Ltd. filed a 6-K on February 15, 2024, announcing its Fourth Quarter 2023 results via a press release titled "Cellebrite Announces Fourth Quarter

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX